共 50 条
- [41] Prognostic impact of distinct combinations of molecular mutations in AML patients after allogeneic stem cell transplantationBONE MARROW TRANSPLANTATION, 2016, 51 : S61 - S61Blau, O.Blau, I. W.Baldus, C.Nogai, A.Rieger, K.Hemmati, P.Jehn, C.Doerken, B.Arnold, R.
- [42] Allogeneic stem cell transplantation for patients with AML and FLT-3 mutationsBONE MARROW TRANSPLANTATION, 2011, 46 : S274 - S275Schleuning, M.Judith, D.Heshmat, M.Burlakova, I.Tschischka, S.Baurmann, H.Schwerdtfeger, R.
- [43] Detection of Recurrent Mutations by Pooled Targeted Next-Generation Sequencing in MDS Patients Prior to Treatment with Hypomethylating Agents or Stem Cell TransplantationBLOOD, 2012, 120 (21)Bejar, RafaelStevenson, Kristen E.Stojanov, PetarZaneveld, J. EricBar-Natan, MichalCaughey, BennettWang, HuiGarcia-Manero, GuillermoKantarjian, Hagop M.Cutler, CoreyRitz, JeromeCibulskis, KristianGetz, GadSteensma, David P.Stone, Richard M.Chen, RuiNeuberg, Donna S.Ebert, Benjamin L.
- [44] NEXT-GENERATION SEQUENCING AS A TOOL FOR ASSESSING MINIMAL RESIDUAL DISEASE IN AML PATIENTS WITH CEBPA MUTATIONSHAEMATOLOGICA, 2015, 100 : 358 - 359Zejskova, L.Plachy, R.Sedlackova, L.Mazal, O.Ondrackova, M.Zavrelova, A.Zak, P.Petecukova, V.Novak, J.Kozak, T.Pekova, S.
- [45] Comparison of two methodologies for monitoring chimerism after allogeneic stem-cell transplantation: Next-generation sequencing (NGS) versus short-tandem repeats (STR)HLA, 2023, 101 (04) : 389 - 389Nino-Ramirez, JairoMedina, AlejandroArnes-Moreta, EstrellaBalanzategui, AnaCorral, RocioAnton, AliciaGarcia-Alvarez, MariaMaldonado, RebecaBastos-Boente, Miguelde la Torre, IgorVidana, Nerea H.Jimenez, CristinaEugenia Sarasquete, MariaCarmen Chillon, M.Hernandez-Ruano, MontserratLucas, Sandra M.Sanchez-Gonzalez, Ana IsabelSanchez-Villares, InmaculadaGonzalez-Calle, OnicaNavarro-Bailon, AlmudenaBoix, FranciscoGil-Etayo, F. JavierTejeda-Velarde, AmaliaGarcia-Sanz, RamonAlcoceba, Miguel
- [46] Mutations Based on Next-Generation Sequencing May be Complementally to Prognostic Risk in Myelodysplastic SyndromesBLOOD, 2020, 136Wang, JingJia, JinsongLiu, XiaohongGong, LizhongLu, ShengyeWang, YuXu, LanpingZhang, XiaohuiYan, ChenhuaLai, YueyunZhao, XiaosuQin, YazhenRuan, GuoruiChang, YingjunShi, HongxiaLiu, KaiyanHuang, XiaojunJiang, Hao
- [47] Impact of cytogenetics on outcome of mismatched unrelated donor hematopoietic stem cell transplantation for adults with AML.BLOOD, 2004, 104 (11) : 237A - 237ATallman, MDewald, GLazarus, HGandham, SNelson, GLogan, BRowe, JLitzow, MKeating, AMehta, JWetzler, MWarren, TWeisdorf, D
- [48] High Resolution Analysis of Post-Allogeneic Stem Cell Transplant Chimerism Using Next-Generation SequencingJOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 862 - 862Mai, M.Viswanatha, D. S.
- [49] Adenovirus infection diagnosed by metagenomic next-generation sequencing after haploidentical hematopoietic stem cell transplantation: A multicenter study in ChinaTRANSPLANT INFECTIOUS DISEASE, 2023, 25 (02)Wu, QiongWu, YanjunZhao, YeZhang, YanmingCao, JunjieWu, DepeiZhou, JuyingChen, Feng
- [50] Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AMLBLOOD, 2020, 136Fuse, KyokoMasuko, MasayoshiMizuno, ShoheiHarada, KaitoUchida, NaoyukiDoki, NorikoFukuda, TakahiroTanaka, MasatsuguOzawa, YukiyasuIkegame, KazuhiroEto, TetsuyaKanda, YoshinobuIchinohe, TatsuoAtsuta, YoshikoYanada, Masamitsu